1
Effect and Safety of Envafolimab Combined With Endostar/S-1 in Second-line of Advanced Non-small Cell Lung Cancer
Condition(s):Carcinoma, Non-Small-Cell LungLast Updated:September 7, 2022Not yet recruiting
Include Studies Not Open or Pending
Condition(s):Carcinoma, Non-Small-Cell LungLast Updated:September 7, 2022Not yet recruiting
Condition(s):Nontuberculous Mycobacterial Lung DiseaseLast Updated:August 10, 2022Not yet recruiting
Condition(s):MDR-TBLast Updated:August 8, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.